Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,466 | -8,318 | -4,371 | -12,969 | -9,697 |
| Depreciation Amortization | 112 | 60 | 48 | 127 | 90 |
| Accounts receivable | -14 | N/A | -6 | 160 | 130 |
| Other Working Capital | 137 | 820 | 685 | -137 | 87 |
| Other Operating Activity | 1,077 | 746 | 414 | 2,077 | 1,575 |
| Operating Cash Flow | $-10,154 | $-6,692 | $-3,231 | $-10,742 | $-7,816 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,052 | 6,913 | 2,938 | -5,394 | -4,962 |
| PPE Investments | -123 | -111 | -119 | -550 | -489 |
| Investing Cash Flow | $8,930 | $6,801 | $2,819 | $-5,944 | $-5,451 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 19,058 | 19,049 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $19,058 | $19,049 |
| Beginning Cash Position | 4,021 | 4,021 | 4,021 | 1,649 | 1,649 |
| End Cash Position | 2,796 | 4,131 | 3,609 | 4,021 | 7,432 |
| Net Cash Flow | $-1,225 | $110 | $-412 | $2,372 | $5,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,154 | -6,692 | -3,231 | -10,742 | -7,816 |
| Capital Expenditure | -123 | -111 | -119 | -550 | -489 |
| Free Cash Flow | -10,277 | -6,803 | -3,350 | -11,293 | -8,305 |